In the present study significant higher cell surface GRP78 in doxorubicin and tunicamycin treated cells correlated with a significantly lower titer of anti GRP78 antibodies in serum compared with non-treated tumor bearing mice. The gene discussed is HSPA5; the disease is neoplasm.